(1) “Cancer” means all malignant neoplasms, regardless of the tissue of origin, including malignant lymphoma, Hodgkin’s disease, and leukemia.
(2) “Health care facility” means hospitals; health care clinics; health centers; skilled nursing facilities; mental health facilities; kidney disease treatment centers, including freestanding hemodialysis units; intermediate care facilities; ambulatory surgical facilities; rehabilitation facilities; health maintenance organizations; and hospice care facilities.
(3) “Health care provider” means a person, corporation, facility or institution licensed in the Territory to provide health care or professional, medical services including a medical, osteopathic, chiropractic or naturopathic physician; hospital; dentist; registered nurse, including an advanced practice registered nurse; optometrist; podiatrist; physical therapist; psychologist; pharmacist and laboratory technician.
(4) “Identifying Information” means a coded description of the type of cancer, the stage to which it has advanced, geographic region, age, sex and ethnicity of the diagnosed person.
(5) “Pathology Laboratory” means any facility that reports the results of examinations of organ tissue, cells, or blood specimens from the human body for cancer to physicians who use the reports for purposes of diagnosis or patient care.
(6) “Registry” means the Virgin Islands Central Cancer Registry Program.
(7) “Reportable Neoplasm” means any form of in-situ or invasive malignant neoplasms, carcinomas, basal cell and squamous cell carcinoma of the skin; lymphoma, including Hodgkin’s and non-Hodgkin’s disease; sarcoma; leukemia; benign and malignant tumor in the central nervous system, or any other malignant growth or neoplastic disease.
(8) “Central Cancer Registry Standard-Setting Organization” means national and international organizations responsible for developing and implementing standards for cancer reporting for central registries.
(9) “Territory” means the Virgin Islands of the United States.